These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 24731657)

  • 1. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.
    Hegele RA; Ginsberg HN; Chapman MJ; Nordestgaard BG; Kuivenhoven JA; Averna M; Borén J; Bruckert E; Catapano AL; Descamps OS; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Raal FJ; Ray KK; Santos RD; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A; Watts GF; Wiklund O;
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):655-66. PubMed ID: 24731657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demystifying the management of hypertriglyceridaemia.
    Watts GF; Ooi EM; Chan DC
    Nat Rev Cardiol; 2013 Nov; 10(11):648-61. PubMed ID: 24060958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation and management of hypertriglyceridaemia.
    Ferns G; Keti V; Griffin B
    J Clin Pathol; 2008 Nov; 61(11):1174-83. PubMed ID: 18955574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review on triglycerides.
    Laufs U; Parhofer KG; Ginsberg HN; Hegele RA
    Eur Heart J; 2020 Jan; 41(1):99-109c. PubMed ID: 31764986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridaemia: an update.
    Wierzbicki AS; Kim EJ; Esan O; Ramachandran R
    J Clin Pathol; 2022 Dec; 75(12):798-806. PubMed ID: 35710321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary hypertriglyceridemia states--General approach and the role of extracorporeal methods.
    Stefanutti C; Julius U
    Atheroscler Suppl; 2015 May; 18():85-94. PubMed ID: 25936310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):515-537. PubMed ID: 31309820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polygenic nature of mild-to-moderate hypertriglyceridemia.
    Dron JS; Wang J; McIntyre AD; Cao H; Hegele RA
    J Clin Lipidol; 2020; 14(1):28-34.e2. PubMed ID: 32033914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How I study hypertriglyceridemia].
    Scheen AJ
    Rev Med Liege; 1998 Feb; 53(2):103-5. PubMed ID: 9564230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertriglyceridemia in the genomic era: a new paradigm.
    Lewis GF; Xiao C; Hegele RA
    Endocr Rev; 2015 Feb; 36(1):131-47. PubMed ID: 25554923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):498-514. PubMed ID: 31060488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
    Bashir B; Ho JH; Downie P; Hamilton P; Ferns G; Datta D; Cegla J; Wierzbicki AS; Dawson C; Jenkinson F; Delaney H; Mansfield M; Teoh Y; Miedzybrodzka Z; Haso H; Durrington PN; Soran H
    Metabolites; 2023 Apr; 13(5):. PubMed ID: 37233662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical heterogeneity in monogenic chylomicronaemia.
    Heidemann BE; Bemelmans RHH; Marais AD; Visseren FLJ; Koopal C
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36423940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypertriglyceridemia is primarily polygenic.
    Dron JS; Wang J; Cao H; McIntyre AD; Iacocca MA; Menard JR; Movsesyan I; Malloy MJ; Pullinger CR; Kane JP; Hegele RA
    J Clin Lipidol; 2019; 13(1):80-88. PubMed ID: 30466821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic pitfalls during therapy for extreme hypertriglyceridaemia.
    Orth M; Luley C
    Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):101-3. PubMed ID: 9056751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary and secondary hypertriglyceridaemia.
    Kolovou GD; Anagnostopoulou KK; Kostakou PM; Bilianou H; Mikhailidis DP
    Curr Drug Targets; 2009 Apr; 10(4):336-43. PubMed ID: 19355858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe hypertriglyceridemia--an important cause of pancreatitis].
    Graesdal A
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1053-6. PubMed ID: 18451886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertriglyceridemia].
    Föger B; Patsch JR
    Wien Med Wochenschr; 1994; 144(12-13):308-11. PubMed ID: 8650934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Genetic Basis of Hypertriglyceridemia.
    Carrasquilla GD; Christiansen MR; Kilpeläinen TO
    Curr Atheroscler Rep; 2021 Jun; 23(8):39. PubMed ID: 34146174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.